Nerandomilast, a PDE4 inhibitor, has shown significant efficacy in progressive pulmonary fibrosis (PPF), offering an ...

A new study reports that a routine, low-cost nutritional assessment tool may offer a powerful way to predict survival in patients with progressive pulmonary fibrosis (PPF), a life-shortening condition ...

For a few moments that evening, the spotlight focused on Ms. Stavros of Pickering, Ont. She was the first in the country who ...

Researching IPF after her late husband's diagnosis meant learning many new acronyms and abbreviations, says guest writer.

Cereno Scientific (Nasdaq First North: CRNO B) (the "Company"), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, annou ...

As of Friday, November 28, 4D Molecular Therapeutics, Inc.’s FDMT share price has surged by 5.19%, which has investors ...

Scientists at NYU Langone discovered that blocking a key protein that shields cancer cells from a natural stress-driven death process can dramatically slow lung tumor growth.

The prescription drug legislation in the Inflation Reduction Act of 2022 — backed by AARP — directed the Department of Health and Human Services to work with pharmaceutical companies to secure reduced ...

Coronary artery disease is one of the leading causes of morbidity and mortality worldwide. Although it can present with an ...

Introduction Atrial fibrosis identified on cardiac magnetic resonance (CMR) imaging has been proposed as a preprocedural ...

Background Interstitial fibrosis in lupus nephritis (LN) is often infiltrated by immune cells but typically regarded as ...